KERNAL Trademark

Trademark Overview


On Monday, July 18, 2022, a trademark application was filed for KERNAL with the United States Patent and Trademark Office. The USPTO has given the KERNAL trademark a serial number of 97507484. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 29, 2024. This trademark is owned by Kernal Biologics. The KERNAL trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes

Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scienti...
kernal

General Information


Serial Number97507484
Word MarkKERNAL
Filing DateMonday, July 18, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements


Goods and ServicesMedical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes
Goods and ServicesChemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, August 8, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKernal Biologics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameKernal Biologics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Thursday, July 21, 2022NEW APPLICATION ENTERED
Monday, August 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 3, 2023ASSIGNED TO EXAMINER
Wednesday, May 3, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 3, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023FINAL REFUSAL WRITTEN
Monday, December 4, 2023FINAL REFUSAL E-MAILED
Monday, December 4, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 1, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, August 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 1, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, August 1, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT